DLB
Dolby Laboratories
58.60$
+1.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +8.6% | +15.5% | -20.8% | +5.5% | +17.1% | +3.5% | -14.6% | -2.7% | +12.9% | +14.1% | -22.9% | – | |
| – | -9.8% | +21.0% | -8.0% | -4.7% | +19.9% | -12.1% | +22.8% | -10.2% | +9.3% | +3.5% | -9.9% | – | |
| – | +11.2% | +14.9% | -22.3% | +7.0% | +16.8% | +5.5% | -18.6% | -1.5% | +13.5% | +15.6% | -24.6% | – | |
| – | -4.8% | -6.8% | +4.8% | +4.8% | -2.9% | -7.4% | +6.9% | +2.2% | +2.4% | -7.9% | +3.3% | – | |
| – | -2.2% | +2.4% | +3.8% | -0.1% | +1.3% | +0.5% | +2.7% | +1.9% | -4.7% | +8.1% | -0.5% | – | |
| – | -7.3% | +3.8% | -3.2% | +6.3% | +2.4% | -4.1% | +1.0% | +6.2% | +1.5% | -2.3% | -4.0% | – | |
| – | +166.8% | +47.2% | -61.6% | +10.3% | +88.8% | +31.6% | -57.5% | -37.7% | +109.5% | +85.2% | -66.8% | – | |
| – | – | – | – | – | – | – | – | – | – | +22.0% | -31.3% | – | |
| – | +794.9% | +50.6% | -58.8% | +19.1% | +44.1% | +39.7% | -53.8% | -24.9% | +71.8% | +67.2% | -63.4% | – | |
| – | – | +77.6% | -55.3% | -91.7% | +1,971.5% | +55.9% | -68.0% | -189.0% | – | +35.3% | -39.8% | – | |
| – | +629.2% | +46.1% | -60.7% | +52.4% | +15.8% | +35.3% | -49.8% | +7.1% | +8.1% | +78.0% | -69.9% | – | |
| – | +205.8% | +40.0% | -49.9% | +17.9% | +32.3% | +30.0% | -50.6% | -15.5% | +69.8% | +42.9% | -56.8% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.